BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17007029)

  • 1. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
    Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
    World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
    He YW; Guo CX; Pan YF; Peng C; Weng ZH
    World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells.
    Huang KL; Lai YK; Lin CC; Chang JM
    J Viral Hepat; 2009 May; 16(5):367-75. PubMed ID: 19228285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
    Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
    World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
    Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX
    World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
    Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
    World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
    He W; Li LX; Liao QJ; Liu CL; Chen XL
    World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein.
    Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X
    Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
    Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
    World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
    Lin M; Yang LY; Li WY; Peng YP; Zheng JK
    J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
    Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
    Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
    Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
    Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
    J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits hepatitis B virus infection by down-regulating cccDNA-bound histone acetylation.
    Wei ZQ; Zhang YH; Ke CZ; Chen HX; Ren P; He YL; Hu P; Ma DQ; Luo J; Meng ZJ
    World J Gastroenterol; 2017 Sep; 23(34):6252-6260. PubMed ID: 28974891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cells.
    Chen HC; Chou CK; Lee SD; Wang JC; Yeh SF
    Antiviral Res; 1995 May; 27(1-2):99-109. PubMed ID: 7486962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.